Physician profile
Jiselle Marie Bock
NPI 1730449273
$29,101.16
in general payments reported to CMS, 2019-2025
16 companies · $22K in 2025
The $22K reported for 2025 was more than what 98% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.13 · 2021: $72.00 · 2024: $7,453 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $21K · Travel and Lodging: $4,592 · Food and Beverage: $2,891 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $21,000.00 |
| Travel and Lodging | $4,592.00 |
| Food and Beverage | $2,891.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,483.53 | 2021-2025 | |
| Davol INC. | $1,813.46 | 2024-2025 | Phasix Mesh |
| Becton, Dickinson and Company | $909.32 | 2024 | Phasix Mesh |
| Tela Bio, INC. | $258.42 | 2024 | Ovitex 2s |
| Boston Scientific Corporation | $151.81 | 2024 | Spyglass Discover |
| Smith+Nephew, INC. | $132.44 | 2024-2025 | Grafix Pl, Renasys Touch, Stravix |
| Kerecis Limited | $96.46 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Urgo Medical North America, LLC | $46.78 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Medtronic, INC. | $41.37 | 2024 | Progrip |
| Teleflex LLC | $34.27 | 2024 | Deknatel |
| Organogenesis INC. | $32.29 | 2024 | |
| Avanos Medical | $27.41 | 2019 | |
| Convatec INC. | $19.58 | 2024 | |
| Portola Pharmaceuticals, LLC | $18.72 | 2019 | |
| Solventum Corporation | $18.56 | 2024 | 3m Coban |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $16.74 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jiselle Bock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.